Aetion

What it does

Aetion is a real-world evidence (RWE) analytics platform used by pharmaceutical companies, biotech firms, regulators, and health systems to analyze real-world data - claims, electronic health records, and patient registries - to generate evidence about drug effectiveness, safety, and value in actual patient populations outside clinical trials. Its AI capabilities include automated study design recommendations that structure analysis protocols to minimize bias, AI-accelerated analysis pipelines that reduce the time from research question to results, and causal inference modeling that controls for confounding factors in observational data. Aetion is used for regulatory submissions, market access negotiations, and clinical decision support - demonstrating drug value with real-world data beyond RCT populations.

Strengths

• Pharmaceutical companies and payers use Aetion to generate and analyze real-world evidence for drug effectiveness and safety - regulatory-grade analyses that inform FDA submissions, payer coverage decisions, and clinical guidelines.
• Aetion is a real-world evidence (RWE) analytics platform used by pharmaceutical companies, biotech firms, regulators, and health systems to analyze real-world data - claims, electronic health records, and patient registries - to generate evidence about drug effectiveness, safety, and value in actual patient populations outside clinical trials.
• Its AI capabilities include automated study design recommendations that structure analysis protocols to minimize bias, AI-accelerated analysis pipelines that reduce the time from research question to results, and causal inference modeling that controls for confounding factors in observational data.

Watch-outs

• Life sciences and regulatory specialty only: Aetion is purpose-built for pharmaceutical real-world evidence — healthcare organizations, health systems, and non-pharma companies have limited applicable use cases.
• Requires specialized data access: Aetion's value depends on access to large claims and EHR datasets — organizations without existing real-world data partnerships or data access agreements cannot leverage the platform without first securing data.
• Regulatory validation required: Real-world evidence used in regulatory submissions requires extensive validation, documentation, and expert biostatistician involvement — Aetion accelerates the analysis but does not eliminate the regulatory expertise requirement.

Pricing

Aetion enterprise contracts not published. Based on number of studies, data access scope, and subscription tier. Annual contracts with implementation.